Historically, the vast majority of revenue that the False Claims Act (FCA), 31 U.S.C. §§ 3729-3733, generates has arisen from cases brought against the health care industry. 1 And a substantial number ...
On February 18, 2025, in United States v. Regeneron Pharmaceuticals, the First Circuit held that to establish civil liability under the False Claims Act (“FCA”) premised on violations of the ...
A Massachusetts federal court decision issued last week in a False Claims Act case highlighted a growing circuit divide over the correct standard of causation for determining a violation of the ...
"This edition of the Healthcare Enforcement column continues to follow recent developments in United States ex rel. Shea v. eHealth, Inc. et al., 21-cv-11777 (DJC) (D. Mass.), a significant False ...